Alembic Pharmaceuticals Limited
APLLTD NSE







Weekly Report
Alembic Pharmaceuticals Limited closed at 950.0000 (-0.16% WoW) . Data window ends Mon, 22 Sep 2025.
How to read this โ Price slope is upward, indicating persistent buying over the window. Low weekly volatility favours steadier follow-through. Volume trend diverges from price โ watch for fatigue or rotation. Returns are negatively correlated with volume โ strength may come on lighter activity. Distance to baseline is narrowing โ reverting closer to its fair-value track. Fresh short-term crossover improves near-term tone.
Up-slope supports buying interest; pullbacks may be contained if activity stays firm. Because liquidity isnโt confirming, prefer evidence of fresh demand before chasing moves.
Gauge maps the trend signal to a 0โ100 scale.
How to read this โ Gauge is elevated but momentum is rolling over; topping risk is rising.
Stay alert: protect gains or seek confirmation before adding risk.
Price is below fair value; potential upside if momentum constructive.
Conclusion
Negative setup. โ โ โโโ confidence. Price window: 0. Trend: Uptrend at Risk; gauge 63. In combination, liquidity diverges from price.
- Momentum is bullish and rising
- Low return volatility supports durability
- High-level but rolling over (topping risk)
- Price is not above key averages
- Liquidity diverges from price
Why: Price window 0.37% over 8w. Close is -2.23% below the prior-window high. Return volatility 1.85%. Volume trend falling. Liquidity divergence with price. Trend state uptrend at risk. 4โ8w crossover bullish. Momentum bullish and rising. Valuation supportive skew.
Tip: Most metrics include a hover tooltip where they appear in the report.